AII
SRPT icon

AGF Investments Inc’s Sarepta Therapeutics SRPT Stock Holding History

AGF Investments Inc’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,114
Closed -$370K – 682
2021
Q4 		$370K Buy
4,114
+1,714
+71% +$147K ﹤0.01% 534
2021
Q3 		$222K Sell
2,400
-122
-5% -$9.4K ﹤0.01% 519
2021
Q2 		$196K Buy
2,522
+2,470
+4,750% +$187K ﹤0.01% 567
2021
Q1 		$4K Sell
52
-3,090
-98% -$285K ﹤0.01% 729
2020
Q4 		$536K Buy
+3,142
New +$466K ﹤0.01% 464
2019
Q4 		– Sell
-50,000
Closed -$3.77M – 366
2019
Q3 		$3.77M Buy
+50,000
New +$5.9M 0.05% 200
2019
Q1 		– Sell
-80,211
Closed -$8.75M – 369
2018
Q4 		$8.75M Buy
+80,211
New +$10M 0.1% 159

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AGF Investments Inc's SRPT Position: Q1 2022 in Review

AGF Investments Inc sold out of Sarepta Therapeutics (SRPT) in Q1 2022, closing a stake of 4,114 shares — an estimated $370K sold.

AGF Investments Inc first reported a position in SRPT in Q4 2018 and held it in 7 quarters. The position peaked at $8.75M in Q4 2018. 328 funds tracked by Wall St. Rank hold SRPT as of Q1 2022.

  • AGF Investments Inc reported no remaining Sarepta Therapeutics position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 4,114 Sarepta Therapeutics shares in Q1 2022, an estimated $370K.
  • AGF Investments Inc first reported a position in Sarepta Therapeutics in Q4 2018 and held it in 7 quarters.
  • AGF Investments Inc's Sarepta Therapeutics position peaked at $8.75M in Q4 2018.
  • 328 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.